Literature DB >> 26046559

Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.

J Correale1, M I Gaitán1.   

Abstract

Pathogenic mechanisms underlying multiple sclerosis development have yet to be clearly identified, but considerable evidence indicates that autoimmunity plays an important role in the etiology of the disease. It is generally accepted that autoimmune diseases like MS arise from complex interactions between genetic susceptibility and environmental factors. Although environmental factors unequivocally influencing MS development have yet to be established, accumulating evidence singles out several candidates, including sunlight-UV exposure or vitamin D deficiency, viral infections, hygiene, and cigarette smoking. Vitamin D deficiency has been associated with different autoimmune diseases. Several investigations indicate 125 (OH)2 vitamin D plays a critical role in shaping T-cell response and inducing T cells with immunosuppressive properties. Likewise, helminth infections represent another potential environmental factor exerting immunomodulatory properties. Both epidemiological and experimental data provide evidence to support autoimmune down-regulation secondary to parasite infections in patients with MS, through regulatory T- and B-cell action, with effects extending beyond simple response to an infectious agent. Finally, different epidemiological studies have demonstrated that Epstein-Barr virus infection confers added risk of developing MS. Proposed mechanisms responsible for this association include activation and expansion of self-reactive T and B cells, lower threshold for self-tolerance breakdown, and enhanced autoreactive B-cell survival, all to be discussed in this review. Understanding environmental factors influencing propensity to MS will lead to new and more effective approaches to prevent and treat the disease.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Epstein-Barr virus; environmental factors; helminth infections; hygiene hypothesis; multiple sclerosis; vitamin D

Mesh:

Substances:

Year:  2015        PMID: 26046559     DOI: 10.1111/ane.12431

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  25 in total

Review 1.  A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Authors:  Shokufeh Ghasemian Sorboni; Hanieh Shakeri Moghaddam; Reza Jafarzadeh-Esfehani; Saman Soleimanpour
Journal:  Clin Microbiol Rev       Date:  2022-01-05       Impact factor: 26.132

Review 2.  The impact of the gut microbiome on extra-intestinal autoimmune diseases.

Authors:  Eiji Miyauchi; Chikako Shimokawa; Alex Steimle; Mahesh S Desai; Hiroshi Ohno
Journal:  Nat Rev Immunol       Date:  2022-05-09       Impact factor: 53.106

3.  Dietary salt intake and time to relapse in paediatric multiple sclerosis.

Authors:  Bardia Nourbakhsh; Jennifer Graves; T Charles Casper; Sabeen Lulu; Amy Waldman; Anita Belman; Benjamin Greenberg; Bianca Weinstock-Guttman; Gregory Aaen; Jan-Mendelt Tillema; Janace Hart; Jayne Ness; Jennifer Rubin; Lauren Krupp; Mark Gorman; Leslie Benson; Moses Rodriguez; Tanuja Chitnis; John Rose; Lisa Barcellos; Emmanuelle Waubant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-06-24       Impact factor: 10.154

4.  EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.

Authors:  Ahmad Nejati; Zabihollah Shoja; Shohreh Shahmahmoodi; Abbas Tafakhori; Yaghoub Mollaei-Kandelous; Farhad Rezaei; Kabir Magaji Hamid; Abbas Mirshafiey; Rozita Doosti; Mohammad Ali Sahraian; Mahmood Mahmoudi; Fazel Shokri; Vince Emery; Sayed Mahdi Marashi
Journal:  Med Microbiol Immunol       Date:  2015-09-13       Impact factor: 3.402

Review 5.  Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Authors:  Justin D Glenn; Ellen M Mowry
Journal:  J Interferon Cytokine Res       Date:  2016-05-04       Impact factor: 2.607

Review 6.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

7.  The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis.

Authors:  Tao Jiang; Lizhuo Li; Ying Wang; Chuntao Zhao; Jundong Yang; Dexuan Ma; Yanlei Guan; Dan Zhao; Yijun Bao; Yunjie Wang; Jingyun Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Obesity and the risk of Multiple Sclerosis. The role of Leptin.

Authors:  Mariano Marrodan; Mauricio F Farez; Maria E Balbuena Aguirre; Jorge Correale
Journal:  Ann Clin Transl Neurol       Date:  2020-12-28       Impact factor: 4.511

Review 9.  HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.

Authors:  Raquel Bello-Morales; Sabina Andreu; Inés Ripa; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 10.  The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.